A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection.

Paola Ballerini,Annick Blaise,Thomas Mercher,Beatrice Pellegrino,Christine Perot,J. van den Akker,E. Gatbois,Mircea Adam,Luc Douay,Berger R,O. Bernard,Judith Landman-Parker

A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection.

2003

Paola Ballerini
Annick Blaise
Thomas Mercher
Beatrice Pellegrino
Christine Perot
J. van den Akker
E. Gatbois
Mircea Adam
Luc Douay
Berger R
O. Bernard
Judith Landman-Parker

A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection

Keywords:

Minimal residual disease
Cancer research
Fusion transcript
Biology
Real-time polymerase chain reaction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations